{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":2,"description":"Individuals in this group will receive a combination of two immunotherapy drugs (nivolumab and ipilimumab) before and after surgery to remove their cancer.\n\nNivolumab: Nivolumab is an immunotherapy drug (a type of drug that helps the immune system fight cancer) that is often used with ipilimumab as the first treatment in adults with mesothelioma whose disease cannot be removed by surgery. The drug will be given as an IV infusion.\n\nIpilimumab: Ipilimumab is a type of immunotherapy drug known as a checkpoint inhibitor, which helps the immune system attack cancer cells.","id":"EG000","otherNumAffected":2,"otherNumAtRisk":2,"seriousNumAffected":2,"seriousNumAtRisk":2,"title":"All Participants in Study Who Have Mesothelioma"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Respiratory, thoracic and mediastinal disorders-Other"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Dry mouth"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Fatigue"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Rash"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Vomiting"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Anorexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Diarrhea"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2}],"term":"Acute kidney injury"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Abdominal pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 5.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2}],"term":"Encephalopathy"}],"timeFrame":"12 weeks"}